rs8103142
| Orientation | plus |
| Stabilized | plus |
| Make rs8103142(C;C) |
| Make rs8103142(C;T) |
| Make rs8103142(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 19 |
| Position | 39244466 |
| Gene | IFNL3 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs8103142 |
| dbSNP (classic) | rs8103142 |
| ClinGen | rs8103142 |
| ebi | rs8103142 |
| HLI | rs8103142 |
| Exac | rs8103142 |
| Gnomad | rs8103142 |
| Varsome | rs8103142 |
| LitVar | rs8103142 |
| Map | rs8103142 |
| PheGenI | rs8103142 |
| Biobank | rs8103142 |
| 1000 genomes | rs8103142 |
| hgdp | rs8103142 |
| ensembl | rs8103142 |
| geneview | rs8103142 |
| scholar | rs8103142 |
| rs8103142 | |
| pharmgkb | rs8103142 |
| gwascentral | rs8103142 |
| openSNP | rs8103142 |
| 23andMe | rs8103142 |
| SNPshot | rs8103142 |
| SNPdbe | rs8103142 |
| MSV3d | rs8103142 |
| GWAS Ctlg | rs8103142 |
| GMAF | 0.2952 |
| Max Magnitude | 0 |
[PMID 19749757] Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
[PMID 21070502] Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort
[PMID 22234924] Combined effects of different IL28B gene variants on the outcome of dual combination therapy in chronic HCV type 1 infection
[PMID 22295096
] Genetic Variations in IL28B and Allergic Disease in Children
[PMID 22328925] Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-? and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients
[PMID 22649509] IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population
[PMID 20887330] High sensitivity assay using serum sample for IL28B genotyping to predict treatment response in chronic hepatitis C patients.
[PMID 21360716] Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.
[PMID 21389156] The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B.
[PMID 22719902] Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus
[PMID 23109451] IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population
[PMID 23866096] The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients
[PMID 25032184] No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients
[PMID 25803108] Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals
